These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37130518)

  • 1. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
    Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
    Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
    World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
    Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.
    Gao Y; Bi D; Xie R; Li M; Guo J; Liu H; Guo X; Fang J; Ding T; Zhu H; Cao Y; Xing M; Zheng J; Xu Q; Xu Q; Wei Q; Qin H
    Signal Transduct Target Ther; 2021 Nov; 6(1):398. PubMed ID: 34795206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene delivery system with autophagy blockade for enhanced anti-angiogenic therapy against Fusobacterium nucleatum-associated colorectal cancer.
    Li N; Yu Y; Chen Q; Niu J; Gao C; Qu X; Zhang J; Gao H
    Acta Biomater; 2024 Jul; 183():278-291. PubMed ID: 38838905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing analysis reveals the distinct features of colorectal cancer with or without
    Ding T; Chen Q; Liu H; Zhang H; Sun Y; Zhao L; Gao Y; Wei Q
    Heliyon; 2024 Sep; 10(18):e37511. PubMed ID: 39309908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis.
    Shigematsu Y; Saito R; Amori G; Kanda H; Takahashi Y; Takeuchi K; Takahashi S; Inamura K
    Cancer Sci; 2024 Oct; 115(10):3248-3255. PubMed ID: 39140431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.
    Wang X; Fang Y; Liang W; Wong CC; Qin H; Gao Y; Liang M; Song L; Zhang Y; Fan M; Liu C; Lau HC; Xu L; Li X; Song W; Wang J; Wang N; Yang T; Mo M; Zhang X; Fang J; Liao B; Sung JJY; Yu J
    Cancer Cell; 2024 Oct; 42(10):1729-1746.e8. PubMed ID: 39303724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of
    Borowsky J; Haruki K; Lau MC; Dias Costa A; Väyrynen JP; Ugai T; Arima K; da Silva A; Felt KD; Zhao M; Gurjao C; Twombly TS; Fujiyoshi K; Väyrynen SA; Hamada T; Mima K; Bullman S; Harrison TA; Phipps AI; Peters U; Ng K; Meyerhardt JA; Song M; Giovannucci EL; Wu K; Zhang X; Freeman GJ; Huttenhower C; Garrett WS; Chan AT; Leggett BA; Whitehall VLJ; Walker N; Brown I; Bettington M; Nishihara R; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    Clin Cancer Res; 2021 May; 27(10):2816-2826. PubMed ID: 33632927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
    Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
    Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.
    Gao Y; Zou T; Xu P; Wang Y; Jiang Y; Chen YX; Chen H; Hong J; Fang JY
    Neoplasia; 2023 Jan; 35():100850. PubMed ID: 36371909
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.